FindTrial
Sign In

Strength Training for patients with Parkinson's Disease identified by a biochemical examination

Resistance Training Program for patients with Parkinson's Disease diagnosed by molecular analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-36cw3y
Enrollment
Unknown
Registered
2017-08-08
Start date
2016-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

All patients were characterized for molecular aspects (mutations), which may be associated with Parkinson's disease in order to investigate if there is a relationship between the genotype and the clin
Other
G11.427.410.698.277

Sponsors

Universidade do Estado do Pará
Lead Sponsor
Universidade do Estado do Pará
Collaborator

Eligibility

Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Volunteers diagnosed with Parkinson's disease by a neurologist specializing in movement disorder; both genders; age greater than or equal to 60 years; stage 1-3 on the Hoehn and Yahr scale; and stable use of medication.

Exclusion criteria

Exclusion criteria: Severe cognitive impairment (Mini-Mental State Exam score <24); inability to walk independently; neurological, cardiopulmonary or orthopedic diseases; have participated in some exercise protocol prior to this project.

Design outcomes

Primary

MeasureTime frame
Increased inspiratory and expiratory muscle strength, analyzed by means of an analog manovacuometer, from the observation of a variation of at least 5% in the pre- and post-intervention measurements;We verified increased inspiratory and expiratory muscle strength after the intervention period. On the other hand, the control group did not present alteration in these variables—

Secondary

MeasureTime frame
Increased quality of life, verified through the Parkinson's Disease Questionnaire (PDQ-39). Reduction of anxiety levels, verified through the Beck Anxiety Inventory. Reduction of Depression symptoms, assessed from the Hamilton Depression Scale. Decreased motor and non-motor symptoms of Parkinson's disease measured from the Unified Scale of Assessment of Patients with Parkinson's Disease (UPDRS). For all data, a variation of at least 5% in the pre- and post-intervention measurements;We found an increase in quality of life, a decrease in anxiety and depression levels, and an improvement in the motor and non-motor symptoms of Parkinson's disease—

Countries

Brazil

Contacts

Public ContactEvitom Sousa

Universidade do Estado do Pará

evitomuepa@gmail.com+55(91)981151234

Outcome results

None listed

Source: REBEC (via WHO ICTRP)